OraSure Technologies, Inc(NASDAQ:OSUR) 
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions. The comp...
Website: http://www.orasure.com
Founded: 1987
Full Time Employees: 472
Sector: Healthcare
Industry: Medical Instruments & Supplies
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2009-06-30 | 2003-12-31 | 2003-09-30 | 2003-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net revenues: | ||||||||||||||||||||||||||||||
products and services | 24,875,000 | 25,336,000 | 29,847,000 | 28,997,000 | 37,232,000 | 39,651,000 | 53,949,000 | 53,779,000 | 75,556,000 | 89,014,000 | 84,738,000 | 152,914,000 | 120,823,000 | 112,821,000 | 79,167,000 | 65,236,000 | 61,348,000 | 53,229,000 | 55,741,000 | 56,579,000 | 60,409,000 | 46,749,000 | 28,337,000 | 30,886,000 | 35,299,000 | 37,267,000 | ||||
other | 1,888,000 | 1,749,000 | 1,395,000 | 934,000 | 213,000 | 264,000 | 386,000 | 353,000 | 325,000 | 173,000 | 703,000 | 2,049,000 | 2,255,000 | 3,642,000 | 1,064,000 | 2,471,000 | 2,220,000 | 688,000 | 1,866,000 | 2,003,000 | 2,446,000 | 1,262,000 | 922,000 | 710,000 | 690,000 | 1,559,000 | ||||
net revenues: - sum | 26,763,000 | 27,085,000 | 31,242,000 | 29,931,000 | 37,445,000 | 39,915,000 | 54,335,000 | 54,132,000 | 75,881,000 | 89,187,000 | 85,441,000 | 154,963,000 | 123,078,000 | 116,463,000 | 80,231,000 | 67,707,000 | 63,568,000 | 53,917,000 | 57,607,000 | 58,582,000 | 62,855,000 | 48,011,000 | 29,259,000 | 31,596,000 | 35,989,000 | 38,826,000 | ||||
cost of products and services sold | 15,795,000 | 15,313,000 | 18,083,000 | 17,632,000 | 23,879,000 | 22,845,000 | 29,646,000 | 30,067,000 | 40,755,000 | 44,847,000 | 59,070,000 | 89,148,000 | 73,489,000 | 70,271,000 | 52,647,000 | 43,435,000 | 36,435,000 | 32,449,000 | 26,934,000 | 20,256,000 | 11,295,500 | 17,722,000 | 11,995,000 | 15,465,000 | ||||||
gross profit | 10,968,000 | 11,772,000 | 13,159,000 | 12,299,000 | 13,566,000 | 17,070,000 | 24,689,000 | 24,065,000 | 35,126,000 | 44,340,000 | 26,371,000 | 65,815,000 | 49,589,000 | 46,192,000 | 27,584,000 | 24,272,000 | 27,133,000 | 21,468,000 | 30,673,000 | 38,326,000 | 38,184,000 | 30,289,000 | 17,264,000 | 16,131,000 | 21,646,000 | 25,018,000 | 9,879,904 | 7,222,086 | 6,329,239 | 5,807,983 |
yoy | -19.15% | -31.04% | -46.70% | -48.89% | -61.38% | -61.50% | -6.38% | -63.44% | -29.17% | -4.01% | -4.40% | 171.16% | 82.76% | 115.17% | -10.07% | -36.67% | -28.94% | -29.12% | 77.67% | 137.59% | 76.40% | 21.07% | 74.74% | 123.36% | 242.00% | 330.75% | ||||
qoq | -6.83% | -10.54% | 6.99% | -9.34% | -20.53% | -30.86% | 2.59% | -31.49% | -20.78% | 68.14% | -59.93% | 32.72% | 7.35% | 67.46% | 13.65% | -10.54% | 26.39% | -30.01% | -19.97% | 0.37% | 26.07% | 75.45% | 7.02% | -25.48% | -13.48% | 153.22% | 36.80% | 14.11% | 8.97% | |
operating expenses: | ||||||||||||||||||||||||||||||
research and development | 11,418,000 | 10,106,000 | 11,401,000 | 9,603,000 | 6,087,000 | 5,623,000 | 6,599,000 | 7,738,000 | 6,991,000 | 8,516,000 | 7,661,000 | 10,560,000 | 8,999,000 | 9,757,000 | 9,068,000 | 8,413,000 | 8,900,000 | 8,596,000 | 7,682,000 | 8,992,000 | 10,457,000 | 8,007,000 | 6,924,000 | 5,644,000 | 4,619,000 | 4,535,000 | 2,432,640 | 1,777,755 | 2,201,946 | 1,965,275 |
sales and marketing | 6,584,000 | 6,299,000 | 6,375,000 | 6,859,000 | 6,992,000 | 7,615,000 | 7,931,000 | 8,448,000 | 6,906,000 | 8,736,000 | 8,535,000 | 12,142,000 | 11,363,000 | 13,474,000 | 11,684,000 | 12,717,000 | 10,915,000 | 13,886,000 | 10,420,000 | 9,530,000 | 9,120,000 | 7,849,000 | 10,121,000 | 7,369,000 | 8,955,000 | 7,687,000 | 5,289,032 | 3,279,109 | 2,512,999 | 2,737,397 |
general and administrative | 9,818,000 | 11,081,000 | 12,676,000 | 14,102,000 | 12,905,000 | 9,831,000 | 11,845,000 | 11,634,000 | 14,005,000 | 10,051,000 | 16,424,000 | 17,711,000 | 15,944,000 | 15,527,000 | 17,579,000 | 19,156,000 | 16,648,000 | 12,499,000 | 10,993,000 | 10,188,000 | 12,211,000 | 10,108,000 | 10,280,000 | 10,054,000 | 7,556,000 | 7,262,000 | 4,434,679 | 1,786,433 | 1,601,819 | 1,657,369 |
loss on impairments | 1,054,000 | 3,338,000 | 3,326,000 | 6,183,000 | 215,000 | 1,105,000 | ||||||||||||||||||||||||
change in the estimated fair value of acquisition-related contingent consideration | 2,983,000 | 376,000 | 733,000 | 478,000 | -40,000 | -35,000 | -24,000 | -152,000 | -36,000 | 41,000 | -500,000 | -220,000 | -806,000 | -1,489,000 | -60,000 | -660,000 | 1,110,000 | -2,387,000 | 249,000 | |||||||||||
gain on sale of assets | 268,000 | -993,000 | ||||||||||||||||||||||||||||
operating expenses: - sum | 31,071,000 | 27,862,000 | 31,185,000 | 30,049,000 | 25,984,000 | 23,069,000 | 27,429,000 | 31,158,000 | 31,228,000 | 33,446,000 | 32,800,000 | 41,494,000 | 36,154,000 | 45,317,000 | 48,873,000 | 40,250,000 | 36,504,000 | 34,481,000 | 28,875,000 | 27,904,000 | 30,299,000 | 25,904,000 | 26,665,000 | 24,177,000 | 8,594,000 | 19,733,000 | 15,184,726 | |||
operating income | -20,103,000 | -16,090,000 | -18,026,000 | -17,750,000 | -12,418,000 | -5,999,000 | -2,740,000 | -7,093,000 | 3,898,000 | 10,894,000 | -6,429,000 | 24,321,000 | 13,435,000 | 875,000 | -21,289,000 | -15,978,000 | -9,371,000 | -13,013,000 | 1,798,000 | 10,422,000 | 7,885,000 | 4,385,000 | -9,401,000 | -8,046,000 | 13,052,000 | 5,285,000 | -5,304,822 | 378,789 | 12,475 | -552,058 |
yoy | 61.89% | 168.21% | 557.88% | 150.25% | -418.57% | -155.07% | -57.38% | -129.16% | -70.99% | 1145.03% | -69.80% | -252.22% | -243.37% | -106.72% | -1284.04% | -253.31% | -218.85% | -396.76% | -119.13% | -229.53% | -39.59% | -17.03% | 77.22% | -2224.14% | 104525.25% | -1057.33% | ||||
qoq | 24.94% | -10.74% | 1.55% | 42.94% | 107.00% | 118.94% | -61.37% | -281.97% | -64.22% | -269.45% | -126.43% | 81.03% | 1435.43% | -104.11% | 33.24% | 70.50% | -27.99% | -823.75% | -82.75% | 32.18% | 79.82% | -146.64% | 16.84% | -161.65% | 146.96% | -199.63% | -1500.47% | 2936.38% | -102.26% | |
other income | 1,671,000 | 2,799,000 | 1,135,000 | 1,778,000 | 2,911,000 | 2,781,000 | 3,066,000 | 3,491,000 | 16,822,000 | 2,612,000 | 1,467,000 | 2,673,000 | 1,961,000 | 3,255,000 | 1,318,000 | -53,000 | 443,000 | 100,000 | 448,000 | -119,000 | -307,000 | 314,000 | 216,000 | 1,430,000 | 1,195,000 | 524,000 | ||||
loss before income taxes and equity investment | -11,538,500 | -13,291,000 | ||||||||||||||||||||||||||||
income tax expense | 210,000 | 47,000 | 2,000,000 | 758,000 | 678,000 | 381,000 | 647,000 | 2,347,000 | -166,000 | -225,000 | -166,000 | -1,143,000 | -1,169,000 | 3,936,000 | 1,465,000 | 2,102,000 | 3,610,000 | 6,529,000 | 5,718,000 | 3,659,000 | 1,309,000 | 712,000 | 1,169,000 | 1,411,000 | ||||||
loss before equity investment | -11,936,250 | -13,338,000 | -18,891,000 | |||||||||||||||||||||||||||
loss on equity investment | -644,000 | -374,000 | -802,000 | -524,000 | -529,000 | -611,000 | -560,000 | |||||||||||||||||||||||
net income | -19,286,000 | -13,712,000 | -19,693,000 | -16,040,000 | -10,794,000 | -4,507,000 | -615,000 | -3,584,000 | 20,073,000 | 11,159,000 | -4,796,000 | 27,219,000 | 15,562,000 | 5,273,000 | -18,802,000 | -19,967,000 | -10,393,000 | -15,015,000 | -1,364,000 | 3,774,000 | 1,860,000 | 1,040,000 | -10,494,000 | -7,328,000 | 13,078,000 | 4,398,000 | -5,159,692 | 434,958 | 52,618 | -530,253 |
yoy | 78.67% | 204.24% | 3102.11% | 347.54% | -153.77% | -140.39% | -87.18% | -113.17% | 28.99% | 111.63% | -74.49% | -236.32% | -249.74% | -135.12% | 1278.45% | -629.07% | -658.76% | -1543.75% | -87.00% | -151.50% | -85.78% | -76.35% | 103.38% | -1784.76% | 24754.61% | -929.42% | ||||
qoq | 40.65% | -30.37% | 22.77% | 48.60% | 139.49% | 632.85% | -82.84% | -117.85% | 79.88% | -332.67% | -117.62% | 74.91% | 195.13% | -128.04% | -5.83% | 92.12% | -30.78% | 1000.81% | -136.14% | 102.90% | 78.85% | -109.91% | 43.20% | -156.03% | 197.36% | -185.24% | -1286.25% | 726.63% | -109.92% | |
loss per share: | ||||||||||||||||||||||||||||||
basic | -0.168 | -0.19 | -0.26 | -0.21 | -0.12 | |||||||||||||||||||||||||
diluted | -0.168 | -0.19 | -0.26 | -0.21 | -0.12 | |||||||||||||||||||||||||
shares used in computing loss per share: | ||||||||||||||||||||||||||||||
basic | -646 | 73,004 | 74,541 | 74,867 | 57 | 72,616 | 72,496 | 72,194 | 19 | 72,023 | 71,983 | 71,878 | 1,417 | 71,537 | 64,745 | 61,927 | 61,726 | 61,709 | ||||||||||||
diluted | -646 | 73,004 | 74,541 | 74,867 | 57 | 72,785 | 72,496 | 72,194 | 19 | 72,023 | 71,983 | 72,766 | 1,417 | 72,662 | 64,745 | 61,927 | 62,143 | 62,128 | ||||||||||||
income before income taxes and equity investment | -16,891,000 | |||||||||||||||||||||||||||||
income before income taxes | -15,972,000 | -9,507,000 | -3,218,000 | 326,000 | -3,602,000 | 20,720,000 | 13,506,000 | -4,962,000 | 26,994,000 | 15,396,000 | 4,130,000 | -19,971,000 | -16,031,000 | -8,928,000 | -12,913,000 | 2,246,000 | 10,303,000 | 7,578,000 | 4,699,000 | -9,185,000 | -6,616,000 | 14,247,000 | 5,809,000 | -5,159,692 | 443,431 | 55,292 | -519,689 | |||
income tax benefit | -456,000 | -18,000 | ||||||||||||||||||||||||||||
income per share: | ||||||||||||||||||||||||||||||
basic | -0.14 | -0.06 | -0.01 | -0.05 | 0.27 | 0.15 | -0.07 | 0.37 | -0.115 | 0.07 | -0.26 | -0.28 | -0.14 | -0.21 | -0.02 | 0.05 | -0.063 | 0.01 | -0.16 | |||||||||||
diluted | -0.14 | -0.06 | -0.01 | -0.05 | 0.27 | 0.15 | -0.07 | 0.37 | -0.115 | 0.07 | -0.26 | -0.28 | -0.14 | -0.21 | -0.02 | 0.05 | -0.063 | 0.01 | -0.16 | |||||||||||
weighted-average shares outstanding: | ||||||||||||||||||||||||||||||
basic | 74,583 | 74,159 | 73,947 | 73,453 | 73,324 | 73,112 | 38,665,545 | |||||||||||||||||||||||
diluted | 74,583 | 74,159 | 73,947 | 74,349 | 73,324 | 73,966 | 39,777,279 | |||||||||||||||||||||||
loss on impairment | 4,275,250 | 6,559,000 | 10,542,000 | |||||||||||||||||||||||||||
shares used in computing income per share: | ||||||||||||||||||||||||||||||
basic | -646 | 73,004 | 74,541 | 74,867 | 57 | 72,616 | 72,496 | 72,194 | 19 | 72,023 | 71,983 | 71,878 | 1,417 | 71,537 | 64,745 | 61,927 | 61,726 | 61,709 | ||||||||||||
diluted | -646 | 73,004 | 74,541 | 74,867 | 57 | 72,785 | 72,496 | 72,194 | 19 | 72,023 | 71,983 | 72,766 | 1,417 | 72,662 | 64,745 | 61,927 | 62,143 | 62,128 | ||||||||||||
gain on sale of business | -10,149,000 | |||||||||||||||||||||||||||||
cost of products sold | 14,343,000 | 13,808,000 | 7,393,657 | 3,820,875 | ||||||||||||||||||||||||||
earnings per share: | ||||||||||||||||||||||||||||||
basic | 0.21 | 0.07 | -0.01 | |||||||||||||||||||||||||||
diluted | 0.21 | 0.07 | -0.01 | |||||||||||||||||||||||||||
shares used in computing earnings per share: | ||||||||||||||||||||||||||||||
basic | -646 | 73,004 | 74,541 | 74,867 | 57 | 72,616 | 72,496 | 72,194 | 19 | 72,023 | 71,983 | 71,878 | 1,417 | 71,537 | 64,745 | 61,927 | 61,726 | 61,709 | ||||||||||||
diluted | -646 | 73,004 | 74,541 | 74,867 | 57 | 72,785 | 72,496 | 72,194 | 19 | 72,023 | 71,983 | 72,766 | 1,417 | 72,662 | 64,745 | 61,927 | 62,143 | 62,128 | ||||||||||||
revenues: | ||||||||||||||||||||||||||||||
product | 16,748,235 | 11,738,231 | 10,221,656 | 9,437,555 | ||||||||||||||||||||||||||
licensing and product development | 525,326 | 142,289 | 109,615 | 191,303 | ||||||||||||||||||||||||||
revenues: - sum | 17,273,561 | 11,880,520 | 10,331,271 | 9,628,858 | ||||||||||||||||||||||||||
impairment of patent and product rights | 3,028,375 | |||||||||||||||||||||||||||||
interest expense | -90,285 | -49,178 | -44,520 | -47,208 | ||||||||||||||||||||||||||
interest income | 236,624 | 178,038 | 78,360 | 83,373 | ||||||||||||||||||||||||||
foreign currency loss | -1,209 | |||||||||||||||||||||||||||||
loss per share: | ||||||||||||||||||||||||||||||
basic and diluted | -0.11 | |||||||||||||||||||||||||||||
shares used in computing loss per share basic and diluted | 45,870,720 | |||||||||||||||||||||||||||||
costs of products sold | 2,850,755.75 | 4,002,032 | ||||||||||||||||||||||||||||
costs and expenses: | ||||||||||||||||||||||||||||||
costs and expenses: - sum | 4,708,068.5 | 6,316,764 | 6,360,041 | |||||||||||||||||||||||||||
foreign currency gain | -64,218 | 8,977 | -3,796 | |||||||||||||||||||||||||||
income taxes | 8,473 | 2,674 | 10,564 | |||||||||||||||||||||||||||
weighted-average number of shares outstanding: | ||||||||||||||||||||||||||||||
basic | 74,583 | 74,159 | 73,947 | 73,453 | 73,324 | 73,112 | 38,665,545 | |||||||||||||||||||||||
diluted | 74,583 | 74,159 | 73,947 | 74,349 | 73,324 | 73,966 | 39,777,279 | |||||||||||||||||||||||
basic and diluted net loss per share | -0.01 | |||||||||||||||||||||||||||||
weighted-average number of shares outstanding | 38,412,351 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2019-09-30 | 2019-06-30 | 2009-06-30 | 2003-12-31 | 2003-09-30 | 2003-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||
cash and cash equivalents | 199,278,000 | 216,478,000 | 234,578,000 | 247,569,000 | 267,763,000 | 278,571,000 | 258,239,000 | 247,145,000 | 290,407,000 | 217,533,000 | 185,936,000 | 90,194,000 | 83,980,000 | 75,205,000 | 66,159,000 | 70,721,000 | 116,762,000 | 134,962,000 | 158,120,000 | 177,676,000 | 160,802,000 | 162,859,000 | 85,465,000 | 72,567,000 | 63,019,261 | 30,695,177 | 3,523,122 | 1,730,494 |
accounts receivable | 22,203,000 | 24,300,000 | 25,900,000 | 21,516,000 | 23,816,000 | 26,954,000 | 38,097,000 | 34,037,000 | 40,171,000 | 53,402,000 | 52,750,000 | 107,445,000 | 70,797,000 | 61,306,000 | 62,886,000 | 59,671,000 | 45,323,000 | 40,075,000 | 35,259,000 | 36,391,000 | 38,835,000 | 30,638,000 | 27,764,000 | 29,390,000 | 11,071,032 | 8,233,869 | 7,024,798 | 6,314,562 |
inventories | 31,060,000 | 33,401,000 | 33,375,000 | 35,677,000 | 34,197,000 | 38,870,000 | 38,255,000 | 43,180,000 | 47,614,000 | 59,264,000 | 73,284,000 | 77,189,000 | 96,232,000 | 78,805,000 | 71,304,000 | 61,536,000 | 53,138,000 | 53,583,000 | 48,170,000 | 40,350,000 | 31,863,000 | 30,488,000 | 25,040,000 | 25,670,000 | 8,662,672 | 4,003,519 | 4,012,433 | 4,170,251 |
prepaid expenses | 5,221,000 | 4,709,000 | 3,336,000 | 5,888,000 | 3,956,000 | 3,038,000 | 3,554,000 | 4,691,000 | 6,041,000 | 6,423,000 | 5,248,000 | 6,161,000 | 6,273,000 | 5,844,000 | 5,477,000 | 8,906,000 | 7,939,000 | 8,103,000 | 5,370,000 | 6,030,000 | 3,860,000 | 2,527,000 | 1,830,000 | 2,128,000 | ||||
other current assets | 4,146,000 | 4,123,000 | 4,249,000 | 3,131,000 | 3,488,000 | 2,718,000 | 3,775,000 | 2,825,000 | 2,226,000 | 12,484,000 | 24,349,000 | 40,428,000 | 41,569,000 | 32,140,000 | 31,855,000 | 26,027,000 | 28,990,000 | 2,439,000 | 2,946,000 | 2,883,000 | 4,934,000 | 3,504,000 | 4,966,000 | 5,057,000 | ||||
total current assets | 261,908,000 | 283,011,000 | 301,438,000 | 313,781,000 | 333,220,000 | 350,151,000 | 351,062,000 | 348,505,000 | 386,459,000 | 356,464,000 | 341,567,000 | 343,595,000 | 325,718,000 | 279,732,000 | 267,306,000 | 268,364,000 | 288,431,000 | 289,227,000 | 285,050,000 | 292,410,000 | 288,893,000 | 302,977,000 | 223,280,000 | 209,258,000 | 100,168,706 | 77,183,995 | 29,501,393 | 26,584,646 |
noncurrent assets: | ||||||||||||||||||||||||||||
property, plant and equipment, net of accumulated depreciation | 39,179,000 | 40,795,000 | 42,155,000 | 43,164,000 | 45,105,000 | 38,143,000 | 40,313,000 | 42,597,000 | 48,027,000 | 49,282,000 | 57,343,000 | |||||||||||||||||
operating right-of-use assets | 11,996,000 | 12,240,000 | 12,703,000 | 12,998,000 | 13,442,000 | 9,904,000 | 10,241,000 | 10,570,000 | 12,270,000 | 13,302,000 | 13,443,000 | 9,922,000 | 10,399,000 | 15,769,000 | 16,451,000 | 12,169,000 | 9,056,000 | 9,615,000 | 10,140,000 | 4,871,000 | 4,461,000 | 4,682,000 | 3,574,000 | 3,685,000 | ||||
finance right-of-use assets | 146,000 | 164,000 | 181,000 | 132,000 | 145,000 | 157,000 | 170,000 | 158,000 | 576,000 | 793,000 | 803,000 | 1,136,000 | 1,293,000 | 1,590,000 | 1,887,000 | 2,240,000 | 2,493,000 | 4,629,000 | 2,484,000 | 1,184,000 | 1,312,000 | 1,462,000 | 1,276,000 | 1,462,000 | ||||
intangible assets, net of accumulated amortization | 19,046,000 | 17,435,000 | ||||||||||||||||||||||||||
goodwill | 43,363,000 | 41,313,000 | 41,745,000 | 40,449,000 | 40,330,000 | 35,287,000 | 34,964,000 | 35,172,000 | 35,696,000 | 35,033,000 | 35,606,000 | 35,204,000 | 35,104,000 | 34,476,000 | 36,038,000 | 40,389,000 | 40,279,000 | 40,264,000 | 40,810,000 | 40,493,000 | 40,351,000 | 39,480,000 | 28,935,000 | 29,280,000 | ||||
investment in equity method investee | 25,956,000 | 26,600,000 | 26,974,000 | 27,776,000 | 28,300,000 | 28,829,000 | 27,773,000 | 28,333,000 | ||||||||||||||||||||
deferred tax asset | 271,000 | 211,000 | 540,000 | 156,000 | 47,000 | 1,230,000 | ||||||||||||||||||||||
other noncurrent assets | 1,303,000 | 1,562,000 | 2,573,000 | 1,460,000 | 1,526,000 | 949,000 | 991,000 | 1,213,000 | 1,218,000 | 973,000 | 998,000 | 1,031,000 | 1,087,000 | 3,538,000 | 1,024,000 | 1,106,000 | 1,215,000 | 1,944,000 | 2,159,000 | 1,944,000 | 1,973,000 | 2,801,000 | 3,971,000 | 3,960,000 | ||||
total noncurrent assets | 141,260,000 | 140,087,000 | 143,597,000 | 143,826,000 | 146,439,000 | 113,934,000 | 115,281,000 | 119,053,000 | 96,386,000 | 101,968,000 | 112,027,000 | 115,820,000 | 118,990,000 | 152,476,000 | 161,948,000 | 167,168,000 | 172,559,000 | 166,530,000 | 179,999,000 | 164,086,000 | 165,579,000 | 133,433,000 | 115,941,000 | 118,207,000 | ||||
total assets | 403,168,000 | 423,098,000 | 445,035,000 | 457,607,000 | 479,659,000 | 464,085,000 | 466,343,000 | 467,558,000 | 482,845,000 | 458,432,000 | 453,594,000 | 459,415,000 | 444,708,000 | 432,208,000 | 429,254,000 | 435,532,000 | 460,990,000 | 455,757,000 | 465,049,000 | 456,496,000 | 454,472,000 | 436,410,000 | 339,221,000 | 327,465,000 | ||||
liabilities and stockholders' equity | ||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||
accounts payable | 6,521,000 | 6,360,000 | 6,380,000 | 7,820,000 | 8,173,000 | 9,581,000 | 9,085,000 | 12,683,000 | 13,151,000 | 14,966,000 | 17,753,000 | 27,396,000 | 39,349,000 | 40,370,000 | 36,226,000 | 27,057,000 | 28,024,000 | 23,778,000 | 22,119,000 | 20,731,000 | 17,407,000 | 14,377,000 | 9,783,000 | 10,956,000 | 2,086,258 | 3,511,148 | 1,776,039 | 1,695,576 |
deferred revenue | 1,518,000 | 1,879,000 | 2,446,000 | 2,510,000 | 2,961,000 | 1,619,000 | 1,445,000 | 1,597,000 | 1,559,000 | 1,824,000 | 1,841,000 | 1,989,000 | 2,273,000 | 2,536,000 | 2,660,000 | 2,906,000 | 2,936,000 | 3,488,000 | 4,240,000 | 4,580,000 | 4,811,000 | 5,311,000 | 3,940,000 | 3,914,000 | ||||
accrued expenses and other current liabilities | 11,149,000 | 12,669,000 | 14,395,000 | 12,960,000 | 20,179,000 | 15,013,000 | 16,199,000 | 12,715,000 | 22,710,000 | 21,140,000 | 23,811,000 | 22,673,000 | 25,762,000 | 25,412,000 | 23,165,000 | 21,911,000 | 33,778,000 | 22,610,000 | 16,899,000 | 17,003,000 | 15,147,000 | 10,974,000 | ||||||
finance lease liability | 63,000 | 63,000 | 62,000 | 42,000 | 41,000 | 41,000 | 515,000 | 517,000 | 539,000 | 1,000,000 | 1,080,000 | 1,229,000 | 1,179,000 | 939,000 | 1,912,000 | 1,017,000 | 522,000 | 517,000 | 536,000 | 439,000 | 448,000 | |||||||
operating lease liability | 2,164,000 | 2,045,000 | 2,086,000 | 2,090,000 | 2,129,000 | 1,530,000 | 1,608,000 | 1,593,000 | 1,577,000 | 2,017,000 | 1,895,000 | 1,761,000 | 1,764,000 | 2,181,000 | 2,178,000 | 2,078,000 | 1,443,000 | 1,125,000 | 1,092,000 | 761,000 | 746,000 | |||||||
acquisition-related contingent consideration obligation | 18,380,000 | 17,232,000 | 16,981,000 | 23,388,000 | 22,910,000 | 40,000 | 75,000 | 65,000 | 199,000 | 199,000 | 199,000 | 206,000 | 201,000 | 219,000 | 365,000 | 402,000 | 764,000 | 3,039,000 | 5,249,000 | |||||||||
total current liabilities | 39,795,000 | 40,248,000 | 42,350,000 | 25,422,000 | 33,483,000 | 27,784,000 | 28,852,000 | 29,105,000 | 39,536,000 | 40,947,000 | 46,420,000 | 55,123,000 | 70,392,000 | 71,697,000 | 65,486,000 | 55,587,000 | 68,064,000 | 54,167,000 | 46,572,000 | 44,644,000 | 46,489,000 | 37,227,000 | 28,936,000 | 29,951,000 | 10,848,303 | 10,013,422 | 8,006,304 | 7,389,995 |
noncurrent liabilities: | ||||||||||||||||||||||||||||
other noncurrent liabilities | 2,243,000 | 2,249,000 | 2,847,000 | 445,000 | 494,000 | 529,000 | 523,000 | 727,000 | 696,000 | 595,000 | 586,000 | 609,000 | 581,000 | 525,000 | 489,000 | 552,000 | 651,000 | 1,998,000 | 2,010,000 | 1,997,000 | 1,682,000 | 2,493,000 | 3,575,000 | 3,538,000 | ||||
total noncurrent liabilities | 22,546,000 | 20,870,000 | 21,964,000 | 35,903,000 | 35,838,000 | 10,736,000 | 11,651,000 | 12,202,000 | 12,638,000 | 12,600,000 | 13,035,000 | 10,113,000 | 10,692,000 | 18,621,000 | 19,576,000 | 15,059,000 | 12,393,000 | 13,770,000 | 13,661,000 | 8,308,000 | 9,412,000 | 11,291,000 | 8,920,000 | 9,293,000 | ||||
total liabilities | 62,341,000 | 61,118,000 | 64,314,000 | 61,325,000 | 69,321,000 | 38,520,000 | 40,503,000 | 41,307,000 | 52,174,000 | 53,547,000 | 59,455,000 | 65,236,000 | 81,084,000 | 90,318,000 | 85,062,000 | 70,646,000 | 80,457,000 | 67,937,000 | 60,233,000 | 52,952,000 | 55,901,000 | 48,518,000 | 37,856,000 | 39,244,000 | ||||
commitments and contingencies | ||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||
preferred stock, par value 0.000001, 25,000 shares authorized, none issued | ||||||||||||||||||||||||||||
common stock | 46 | 44 | 39 | 38 | ||||||||||||||||||||||||
additional paid-in capital | 531,393,000 | 535,029,000 | 537,256,000 | 539,875,000 | 538,129,000 | 535,402,000 | 532,601,000 | 531,263,000 | 529,543,000 | 526,261,000 | 523,861,000 | 521,964,000 | 520,446,000 | 518,170,000 | 515,928,000 | 513,553,000 | 511,063,000 | 508,601,000 | 506,304,000 | 504,949,000 | 505,123,000 | 502,802,000 | 401,014,000 | 399,585,000 | 237,352,061 | 204,867,765 | 159,230,306 | 157,191,210 |
accumulated other comprehensive loss | -18,404,000 | -20,173,000 | -17,371,000 | -24,122,000 | -24,360,000 | -17,200,000 | -18,631,000 | -17,497,000 | -14,941,000 | -17,372,000 | -14,559,000 | -17,418,000 | -18,435,000 | -22,331,000 | -12,514,000 | -8,247,000 | -10,077,000 | -10,721,000 | -6,443,000 | -7,724,000 | -9,097,000 | -15,595,000 | -14,678,000 | -13,315,000 | -214,358 | -173,704 | -195,134 | -182,250 |
accumulated deficit | -172,162,000 | -152,876,000 | -139,164,000 | -119,471,000 | -103,431,000 | -92,637,000 | -88,130,000 | -87,515,000 | -83,931,000 | -104,004,000 | -115,163,000 | -110,367,000 | -138,387,000 | -153,949,000 | -159,222,000 | -140,420,000 | -120,453,000 | -110,060,000 | -95,045,000 | -93,681,000 | -97,455,000 | -99,315,000 | -84,971,000 | -98,049,000 | -134,053,006 | -130,570,301 | -131,005,259 | -131,057,877 |
total stockholders' equity | 340,827,000 | 361,980,000 | 380,721,000 | 396,282,000 | 410,338,000 | 425,565,000 | 425,840,000 | 426,251,000 | 430,671,000 | 404,885,000 | 394,139,000 | 394,179,000 | 363,624,000 | 341,890,000 | 344,192,000 | 364,886,000 | 380,533,000 | 387,820,000 | 404,816,000 | 403,544,000 | 398,571,000 | 387,892,000 | 301,365,000 | 288,221,000 | ||||
total liabilities and stockholders' equity | 403,168,000 | 423,098,000 | 445,035,000 | 457,607,000 | 479,659,000 | 464,085,000 | 466,343,000 | 467,558,000 | 482,845,000 | 458,432,000 | 453,594,000 | 459,415,000 | 444,708,000 | 432,208,000 | 429,254,000 | 435,532,000 | 460,990,000 | 455,757,000 | 465,049,000 | 456,496,000 | 454,472,000 | 436,410,000 | 339,221,000 | 327,465,000 | ||||
intangible assets, net of accumulated amortization of 26,802 and 32,413 | 17,202,000 | |||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 27,234 and 32,413 | 17,266,000 | |||||||||||||||||||||||||||
preferred stock, par value .000001, 25,000 shares authorized, none issued | ||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,990 and 32,413 | 17,307,000 | |||||||||||||||||||||||||||
deferred income taxes | 671,000 | 627,000 | 595,000 | 554,000 | 409,000 | 408,000 | 2,551,000 | 2,547,000 | 2,456,000 | 2,234,000 | 880,000 | 1,008,000 | 1,118,000 | 1,195,000 | 749,000 | 1,078,000 | 910,000 | |||||||||||
intangible assets, net of accumulated amortization of 33,711 and 33,649 | 665,000 | |||||||||||||||||||||||||||
short-term investments | 9,142,000 | 16,627,000 | 7,358,000 | 22,178,000 | 26,867,000 | 26,432,000 | 29,625,000 | 41,503,000 | 36,279,000 | 50,065,000 | 35,185,000 | 29,080,000 | 48,599,000 | 72,961,000 | 78,215,000 | 74,446,000 | 16,143,003 | 33,328,610 | 14,168,657 | 13,677,720 | ||||||||
intangible assets, net of accumulated amortization of 33,200 and 33,649 | 829,000 | |||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 33,261 and 33,649 | 1,010,000 | |||||||||||||||||||||||||||
property, plant and equipment | 45,420,000 | 59,413,000 | 85,184,000 | 93,697,000 | 97,572,000 | 88,164,000 | 77,586,000 | 72,034,000 | 64,943,000 | 51,860,000 | 39,056,000 | 29,045,000 | 27,793,000 | |||||||||||||||
intangible assets | 1,206,000 | 11,694,000 | 11,919,000 | 12,851,000 | 13,692,000 | 14,343,000 | 15,221,000 | 16,241,000 | 16,945,000 | 17,904,000 | 18,111,000 | 11,577,000 | 12,472,000 | |||||||||||||||
intangible assets, net of accumulated amortization of 27,336 and 31,077 | 3,793,000 | |||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 32,737 and 31,077 | 10,665,000 | |||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 31,732 and 31,077 | 11,184,000 | |||||||||||||||||||||||||||
long-term investments | 17,009,000 | 17,271,000 | 36,131,000 | 33,706,000 | 47,718,000 | 27,841,000 | 37,563,000 | 39,555,000 | ||||||||||||||||||||
finance lease liabilities | 1,242,000 | 1,182,000 | 1,699,000 | |||||||||||||||||||||||||
operating lease liabilities | 1,938,000 | 2,054,000 | 1,815,000 | |||||||||||||||||||||||||
accrued expenses | 22,227,000 | 8,638,000 | 5,375,851 | 5,104,684 | 4,556,648 | |||||||||||||||||||||||
prepaid expenses and other | 1,272,738 | 922,820 | 772,383 | 691,619 | ||||||||||||||||||||||||
property and equipment | 20,774,959 | 6,471,209 | 6,782,896 | 7,103,241 | ||||||||||||||||||||||||
patents and product rights | 956,252 | 1,886,171 | 2,051,920 | 2,217,372 | ||||||||||||||||||||||||
other assets | 79,816 | 609,932 | 615,801 | 625,286 | ||||||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||
current portion of long-term debt | 538,854 | 1,126,423 | 1,125,581 | 1,137,771 | ||||||||||||||||||||||||
accrued expenses and other | 8,223,191 | |||||||||||||||||||||||||||
long-term debt | 8,041,679 | 2,456,454 | 2,738,855 | 3,007,774 | ||||||||||||||||||||||||
other liabilities | 5,008 | 172,142 | 176,899 | 181,655 | ||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||
preferred stock, par value .000001, 25,000,000 shares authorized, none issued | ||||||||||||||||||||||||||||
total stockholders’ equity | 103,084,743 | 73,509,289 | 28,029,952 | 25,951,121 | ||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||||
preferred stock, par value .000001; 25,000,000 shares authorized, none issued | ||||||||||||||||||||||||||||
deferred compensation | -614,515 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2019-09-30 | 2003-12-31 | 2003-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities: | |||||||||||||||||||||
net income | -10,794,000 | -4,507,000 | -615,000 | -3,584,000 | 20,073,000 | 11,159,000 | -4,796,000 | 27,219,000 | 5,273,000 | -18,802,000 | -19,967,000 | 13,078,000 | |||||||||
adjustments to reconcile net income to net cash from operating activities | |||||||||||||||||||||
stock-based compensation | 1,460,000 | 2,835,000 | 3,165,000 | 2,687,000 | 2,742,000 | 2,888,000 | 3,322,000 | 2,968,000 | 3,127,000 | 2,590,000 | 2,357,000 | 2,655,000 | 2,522,000 | 2,296,000 | 3,280,000 | 3,524,000 | 2,652,000 | 2,218,000 | 1,435,000 | ||
depreciation and amortization | 2,403,000 | 2,455,000 | 2,526,000 | 2,808,000 | 2,492,000 | 3,049,000 | 2,606,000 | 2,725,000 | 3,564,000 | 3,361,000 | 10,315,000 | 3,696,000 | 3,917,000 | 3,927,000 | 3,782,000 | 3,682,000 | 3,179,000 | 3,335,000 | 1,922,000 | 662,775 | 644,517 |
loss on impairments | 0 | 0 | 1,054,000 | 3,338,000 | 3,326,000 | 6,183,000 | 215,000 | 1,105,000 | |||||||||||||
other non-cash amortization | -1,000 | -74,000 | -110,000 | -37,000 | 5,000 | -481,000 | -94,000 | 6,000 | 0 | 2,000 | -183,000 | 98,000 | 233,000 | 80,000 | 173,000 | 284,000 | |||||
provision for credit losses | 111,000 | 120,000 | -48,000 | -248,000 | -450,000 | 372,000 | 234,000 | -85,000 | -387,000 | 403,000 | -411,000 | -67,000 | |||||||||
unrealized foreign currency loss | 71,000 | -176,000 | 276,000 | 194,000 | 71,000 | -119,000 | 44,000 | 169,000 | -93,000 | ||||||||||||
interest expense on finance leases | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 7,000 | 6,000 | 7,000 | 9,000 | 14,000 | 13,000 | 15,000 | 20,000 | 19,000 | 23,000 | 32,000 | -2,000 | 49,000 | 10,000 | ||
loss on equity investment | 644,000 | 374,000 | 802,000 | 524,000 | 529,000 | 611,000 | |||||||||||||||
deferred income taxes | 1,939,000 | 734,000 | -436,000 | -384,000 | -822,000 | 74,000 | 38,000 | 53,000 | 592,000 | 1,325,000 | -2,193,000 | 181,000 | 161,000 | 200,000 | 1,350,000 | -106,000 | 176,000 | ||||
loss on sale of fixed assets | 684,000 | ||||||||||||||||||||
change in the estimated fair value of acquisition-related contingent consideration | 2,983,000 | 376,000 | 733,000 | 478,000 | 0 | -40,000 | -35,000 | -24,000 | -152,000 | 0 | 0 | -36,000 | 41,000 | -500,000 | -2,387,000 | ||||||
payment of acquisition-related contingent consideration | 0 | 0 | 0 | -19,000 | 0 | 0 | |||||||||||||||
changes in assets and liabilities: | |||||||||||||||||||||
accounts receivable | 1,965,000 | 1,547,000 | -3,976,000 | 2,413,000 | 3,214,000 | 10,856,000 | -4,397,000 | 6,199,000 | 13,648,000 | -1,184,000 | 55,265,000 | -36,613,000 | -6,010,000 | -506,000 | -3,351,000 | -15,295,000 | -4,349,000 | -5,782,000 | -445,000 | -1,209,071 | -710,236 |
inventories | 2,668,000 | -115,000 | 2,491,000 | -1,482,000 | 4,437,000 | -561,000 | 4,883,000 | 4,337,000 | 11,803,000 | 13,869,000 | 4,016,000 | 18,540,000 | -15,462,000 | -7,201,000 | -11,011,000 | -9,374,000 | -6,252,000 | -5,624,000 | -957,000 | -92,664 | 48,161 |
prepaid expenses and other assets | -453,000 | -1,232,000 | 1,392,000 | -2,075,000 | 1,467,000 | 895,000 | 1,124,000 | 603,000 | -13,029,000 | 5,035,000 | 196,000 | 5,299,000 | -1,101,000 | -1,574,000 | -3,680,000 | -736,000 | -6,732,000 | -2,096,000 | 806,000 | 143,927 | |
accounts payable | 13,000 | -185,000 | -822,000 | -726,000 | -4,146,000 | 38,000 | -3,401,000 | -68,000 | -1,854,000 | -2,935,000 | -10,090,000 | -12,097,000 | -12,283,000 | 4,304,000 | 7,544,000 | 4,398,000 | 444,000 | -1,610,000 | -1,123,000 | ||
deferred revenue | -434,000 | -565,000 | -69,000 | -451,000 | -285,000 | 171,000 | -152,000 | 47,000 | -281,000 | 1,000 | -171,000 | -279,000 | -284,000 | -60,000 | -208,000 | -44,000 | -560,000 | -701,000 | 47,000 | ||
accrued expenses and other liabilities | -3,349,000 | -2,242,000 | 3,544,000 | -6,616,000 | 1,143,000 | -503,000 | 2,605,000 | -9,688,000 | 606,000 | -2,664,000 | 2,146,000 | -3,472,000 | 1,137,000 | 3,192,000 | 1,644,000 | -4,603,000 | 2,306,000 | 5,896,000 | 1,629,000 | ||
net cash from operating activities | -8,996,000 | -10,071,000 | -10,223,000 | -19,733,000 | 109,000 | 12,682,000 | 7,845,000 | 6,738,000 | 41,366,000 | 36,947,000 | 57,268,000 | 6,002,000 | -18,012,000 | 16,299,000 | -9,668,000 | -35,821,000 | -12,784,000 | -19,126,000 | 6,177,000 | 1,767,489 | 661,149 |
capital expenditures | -922,000 | -919,000 | -1,936,000 | -420,000 | -456,000 | -145,000 | -1,617,000 | -1,285,000 | -2,091,000 | -2,969,000 | -3,958,000 | 2,877,000 | -7,543,000 | -10,836,000 | -48,407,000 | -9,114,000 | -4,579,000 | -2,448,000 | -131,536 | -131,342 | |
free cash flows | -9,918,000 | -10,990,000 | -12,159,000 | -20,153,000 | -347,000 | 12,537,000 | 6,228,000 | 40,081,000 | 34,856,000 | 54,299,000 | 2,044,000 | -15,135,000 | 8,756,000 | -20,504,000 | -84,228,000 | -21,898,000 | -23,705,000 | 3,729,000 | 1,635,953 | 529,807 | |
investing activities: | |||||||||||||||||||||
purchases of short-term investments | 0 | 0 | -27,394,000 | -25,850,000 | 0 | -23,284,535 | -3,813,723 | ||||||||||||||
proceeds from maturities and redemptions of investments | 1,000 | 27,304,000 | 0 | 24,398,000 | 10,882,000 | 12,135,000 | 14,180,000 | 10,000,000 | 35,827,000 | ||||||||||||
purchase of equity method investee | 0 | -28,333,000 | |||||||||||||||||||
acquisition of business, net of cash acquired | |||||||||||||||||||||
proceeds from sale of assets | 112,000 | 98,000 | 0 | 790,000 | |||||||||||||||||
purchases of property and equipment | -922,000 | -919,000 | -1,936,000 | -420,000 | -456,000 | -145,000 | -1,617,000 | -1,579,000 | -1,285,000 | -1,624,000 | -1,702,000 | -1,191,000 | 21,307,000 | -2,641,000 | -5,221,000 | -20,219,000 | -9,114,000 | -4,579,000 | -2,448,000 | -131,536 | -131,342 |
purchase of property and equipment under government contracts | 0 | -467,000 | -1,267,000 | -2,767,000 | -18,430,000 | -4,902,000 | -5,615,000 | -28,188,000 | |||||||||||||
proceeds from funding under government contracts | |||||||||||||||||||||
net cash from investing activities | -4,423,000 | -821,000 | -5,493,000 | 7,332,000 | 5,663,000 | -46,528,000 | 30,554,000 | -2,571,000 | 37,155,000 | 1,016,000 | 25,573,000 | -2,224,000 | 7,675,000 | -9,939,000 | -6,277,000 | -9,594,000 | 8,523,000 | -19,289,633 | -635,478 | ||
financing activities: | |||||||||||||||||||||
cash payments for lease liabilities | -18,000 | -96,000 | -639,000 | -57,000 | -50,000 | -510,000 | -515,000 | -172,000 | -148,000 | -555,000 | -434,000 | -239,000 | -153,000 | 425,000 | -601,000 | ||||||
proceeds from exercise of stock options | 0 | -1,000 | 0 | 215,000 | 193,000 | 10,000 | 0 | 66,000 | 0 | 0 | 0 | 15,000 | -1,000 | 126,000 | 0 | ||||||
repurchase of common stock | -5,039,000 | -5,001,000 | -15,000 | -87,000 | -1,984,000 | -1,462,000 | -38,000 | -200,000 | -460,000 | -1,203,000 | -246,000 | -54,000 | -905,000 | -1,049,000 | -189,000 | -47,000 | -7,000 | ||||
payment of taxes related to net share settlement of equity awards | -57,000 | -61,000 | |||||||||||||||||||
net cash from financing activities | -5,114,000 | -5,079,000 | -5,798,000 | -953,000 | -111,000 | -727,000 | -2,041,000 | -1,297,000 | -355,000 | -705,000 | -632,000 | -1,331,000 | -801,000 | -488,000 | -1,144,000 | -1,395,000 | 235,000 | -522,000 | -136,000 | 44,705,242 | 1,757,988 |
effect of foreign exchange rate changes on cash | 1,333,000 | -2,129,000 | 4,966,000 | 122,000 | -5,313,000 | 1,044,000 | -372,000 | -2,175,000 | 1,309,000 | -2,074,000 | 1,951,000 | 527,000 | 2,015,000 | -4,541,000 | -1,425,000 | 1,114,000 | 626,000 | 6,084,000 | -1,666,000 | -11,043 | 8,969 |
net increase in cash and cash equivalents | -10,808,000 | 20,332,000 | 11,094,000 | -43,262,000 | 72,874,000 | 31,597,000 | 95,742,000 | 6,214,000 | -46,041,000 | -18,200,000 | -23,158,000 | 27,172,055 | |||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 0 | 267,763,000 | 0 | 0 | 0 | 290,407,000 | 0 | 0 | 0 | 83,980,000 | 0 | 0 | 0 | 116,762,000 | 0 | 0 | 0 | 0 | |
cash and cash equivalents, end of period | -17,200,000 | -18,100,000 | -12,991,000 | 247,569,000 | -10,808,000 | 20,332,000 | 11,094,000 | 247,145,000 | 72,874,000 | 31,597,000 | 95,742,000 | 90,194,000 | 8,775,000 | 9,046,000 | -4,562,000 | 70,721,000 | -18,200,000 | -23,158,000 | 12,898,000 | 1,792,628 | |
net loss | -13,712,000 | -19,693,000 | -16,040,000 | -10,393,000 | 434,958 | 52,618 | |||||||||||||||
adjustments to reconcile net loss to net cash from operating activities | |||||||||||||||||||||
gain on sale of fixed assets | -213,000 | 0 | -780,000 | ||||||||||||||||||
proceeds from maturities and redemptions of short-term investments | 0 | 9,144,000 | 34,674,000 | 9,234,000 | 7,460,000 | ||||||||||||||||
net decrease in cash and cash equivalents | -18,100,000 | -12,991,000 | -20,194,000 | 9,046,000 | |||||||||||||||||
supplemental disclosures of cash flow information: | |||||||||||||||||||||
cash paid for income taxes | 3,000 | 783,000 | 1,796,000 | 633,000 | -10,000 | 293,000 | 5,537,000 | 3,570,000 | 2,211,000 | 1,373,000 | |||||||||||
non-cash investing and financing activities | |||||||||||||||||||||
accrued property and equipment purchases | 190,000 | 19,000 | 163,000 | -535,000 | 167,000 | 471,000 | -159,000 | -419,000 | 733,000 | -437,000 | 1,258,000 | 642,000 | 3,486,000 | -13,000 | |||||||
purchases of investments | -22,330,000 | 0 | -379,000 | -15,015,000 | -36,856,000 | ||||||||||||||||
cash payments for finance lease liabilities | -14,000 | -12,000 | |||||||||||||||||||
supplemental disclosures of cash flow information | |||||||||||||||||||||
net cash from in investing activities | 370,000 | ||||||||||||||||||||
withholding and retirement of common stock | -941,000 | ||||||||||||||||||||
proceeds from funding under government contract | 24,379,000 | 6,497,000 | 22,575,000 | 3,794,000 | 7,629,000 | 26,333,000 | |||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
unrealized foreign currency gain | -172,000 | -334,000 | |||||||||||||||||||
investment in equity method investee | |||||||||||||||||||||
cash (refunds) paid for income taxes | 592,000 | ||||||||||||||||||||
accrued property and equipment purchases under government contracts | 351,000 | 118,000 | 1,905,000 | ||||||||||||||||||
other investing activities | |||||||||||||||||||||
unrealized gain on marketable securities | 11,000 | 82,000 | 74,000 | -161,000 | 194,000 | ||||||||||||||||
changes in assets and liabilities | |||||||||||||||||||||
non-cash investing activities | |||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||
provision for doubtful accounts | -2,006,000 | 1,126,000 | -499,000 | 347,000 | -1,481,000 | 481,000 | |||||||||||||||
inventory reserve | -1,731,000 | -1,012,000 | 897,000 | 1,092,000 | |||||||||||||||||
gain on sale of product line | |||||||||||||||||||||
purchase of patent and product rights | |||||||||||||||||||||
acquisition of businesses, net of cash acquired | 0 | ||||||||||||||||||||
issuance of common stock in connection with public offering | |||||||||||||||||||||
loss on impairment | 6,559,000 | ||||||||||||||||||||
loss on disposal of fixed assets | 11,000 | 8,000 | 710,000 | ||||||||||||||||||
gain on sale of business | |||||||||||||||||||||
proceeds from sale of business | |||||||||||||||||||||
repayments of loans | 0 | ||||||||||||||||||||
proceeds from escrow associated with business acquisitions | |||||||||||||||||||||
purchase price adjustment related to business acquisition | 0 | ||||||||||||||||||||
cash payments for lease liability | -129,000 | ||||||||||||||||||||
impairment of patent and product rights | |||||||||||||||||||||
reserve for excess and obsolete inventories | |||||||||||||||||||||
purchase of short-term investments | |||||||||||||||||||||
purchase of property and equipment | |||||||||||||||||||||
payments of patents and licenses | |||||||||||||||||||||
repayments of long-term debt | |||||||||||||||||||||
proceeds from issuance of common stock | 2,039,097 | ||||||||||||||||||||
purchase and retirement of common stock | |||||||||||||||||||||
cash paid for: | |||||||||||||||||||||
interest | |||||||||||||||||||||
income taxes | |||||||||||||||||||||
stock based compensation expense | |||||||||||||||||||||
amortization of deferred revenue | |||||||||||||||||||||
gain on sale of securities and disposition of investment in affiliated company | |||||||||||||||||||||
loss on disposition of property and equipment | |||||||||||||||||||||
provision for excess and obsolete inventories | |||||||||||||||||||||
changes in assets and liabilities- | |||||||||||||||||||||
notes receivable | |||||||||||||||||||||
prepaid expenses and other | |||||||||||||||||||||
accrued expenses and other | |||||||||||||||||||||
proceeds from the sale of property and equipment | |||||||||||||||||||||
purchase of patents, licenses and product rights | |||||||||||||||||||||
proceeds from sales or maturities of short-term investments | |||||||||||||||||||||
proceeds from sale of securities | |||||||||||||||||||||
proceeds from disposition of investment in affiliated company | |||||||||||||||||||||
increase in other assets | -4,526 | -910 | |||||||||||||||||||
borrowings of term debt | |||||||||||||||||||||
repayment of term debt | |||||||||||||||||||||
proceeds from stock option exercises | |||||||||||||||||||||
proceeds from common stock offering | |||||||||||||||||||||
cash and cash equivalents, beginning of year | |||||||||||||||||||||
cash and cash equivalents, end of year | |||||||||||||||||||||
stock-based compensation expense | |||||||||||||||||||||
write-off of inventory | 109,657 | ||||||||||||||||||||
notes receivable from officer | |||||||||||||||||||||
accounts payable and accrued expenses | 372,505 | ||||||||||||||||||||
proceeds from the sale of short-term investments | 3,310,497 | ||||||||||||||||||||
purchase of patents and product rights | |||||||||||||||||||||
borrowings of long-term debt | |||||||||||||||||||||
repayments of term debt |